# Castle Biosciences Inc: Form 8-K, filed Jan 9, 2023

- Company: [Castle Biosciences Inc](/companies/cstl.md) (CIK 1447362)
- Form: 8-K
- Filed: 2023-01-09
- Accepted by EDGAR: Jan 9, 2023, 10:19 ET
- Period: 2023-01-08
- Accession: 0001447362-23-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447362/000144736223000007/cstl-20230108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447362/000144736223000007/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447362/000144736223000007/cstl-20230108.htm

Filed Jan 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001447362-23-000007. Last ingested by Listed: Nov 5, 2026, 17:16 ET. No prices; not investment advice.